<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Maharjan S</submitter><funding>NIA NIH HHS</funding><funding>Foundation for the National Institutes of Health</funding><funding>NCI NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>9008</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11489592</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(1)</volume><pubmed_abstract>Human mitochondrial tRNAs (mt-tRNAs), critical for mitochondrial biogenesis, are frequently associated with pathogenic mutations. These mt-tRNAs have unusual sequence motifs and require post-transcriptional modifications to stabilize their fragile structures. However, whether a modification that stabilizes a wild-type (WT) mt-tRNA would also stabilize its pathogenic variants is unknown. Here we show that the N&lt;sup>1&lt;/sup>-methylation of guanosine at position 9 (m&lt;sup>1&lt;/sup>G9) of mt-Leu(UAA), while stabilizing the WT tRNA, has a destabilizing effect on variants associated with MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes). This differential effect is further demonstrated, as removal of the m&lt;sup>1&lt;/sup>G9 methylation, while damaging to the WT tR</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Post-transcriptional methylation of mitochondrial-tRNA differentially contributes to mitochondrial pathology.</pubmed_title><pmcid>PMC11489592</pmcid><funding_grant_id>R35 GM149336</funding_grant_id><funding_grant_id>R35 GM134931</funding_grant_id><funding_grant_id>R01 AG078814</funding_grant_id><funding_grant_id>R01 GM123771</funding_grant_id><funding_grant_id>R01 CA259635</funding_grant_id><pubmed_authors>Maharjan S</pubmed_authors><pubmed_authors>Suzuki T</pubmed_authors><pubmed_authors>Christian T</pubmed_authors><pubmed_authors>Seifert E</pubmed_authors><pubmed_authors>Li NS</pubmed_authors><pubmed_authors>Gamper H</pubmed_authors><pubmed_authors>Hou YM</pubmed_authors><pubmed_authors>Wanunu M</pubmed_authors><pubmed_authors>Yamaki Y</pubmed_authors><pubmed_authors>Henley RY</pubmed_authors><pubmed_authors>Wallace DC</pubmed_authors><pubmed_authors>Piccirilli JA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Post-transcriptional methylation of mitochondrial-tRNA differentially contributes to mitochondrial pathology.</name><description>Human mitochondrial tRNAs (mt-tRNAs), critical for mitochondrial biogenesis, are frequently associated with pathogenic mutations. These mt-tRNAs have unusual sequence motifs and require post-transcriptional modifications to stabilize their fragile structures. However, whether a modification that stabilizes a wild-type (WT) mt-tRNA would also stabilize its pathogenic variants is unknown. Here we show that the N&lt;sup>1&lt;/sup>-methylation of guanosine at position 9 (m&lt;sup>1&lt;/sup>G9) of mt-Leu(UAA), while stabilizing the WT tRNA, has a destabilizing effect on variants associated with MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes). This differential effect is further demonstrated, as removal of the m&lt;sup>1&lt;/sup>G9 methylation, while damaging to the WT tR</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2026-06-03T07:18:32.077Z</modification><creation>2025-04-06T09:33:37.982Z</creation></dates><accession>S-EPMC11489592</accession><cross_references><pubmed>39424798</pubmed><doi>10.1038/s41467-024-53318-x</doi></cross_references></HashMap>